Evidence map›Paper›PMID 42214517›Full record

SynthesisNeuroscience and biobehavioral reviews2026

Noninvasive brain stimulation combined with evidence-based psychotherapy for psychiatric disorders: A meta-analysis of optimal implementation parameters.

Lysianne Beynel, Eva Wiener, Neil Baker, Ethan Greenstein, Andrada D Neacsiu, Eudora Jones, Brian Gindoff, Sunday M Francis, Cecilia Neige, Marine Mondino and 4 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Neuroscience and biobehavioral reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Lysianne BeynelNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Eva WienerInterventional Psychiatry Research Program, Department of Psychiatry, University of California San Diego, San Diego, CA, United States. Electronic address: ewiener@health.ucsd.edu.
Neil BakerNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Ethan GreensteinNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Andrada D NeacsiuDuke Center for Misophonia and Emotion Regulation, Duke Brain Stimulation Research Center, Department of Psychiatry and Behavioral Neuroscience, School of Medicine, Duke University, Durham, NC, United States.
Eudora JonesNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Brian GindoffGarnet Health Medical Center, Middletown, NY, United States.
Sunday M FrancisNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Cecilia NeigeLe Vinatier, Psychiatrie Universitaire Lyon Métropole, Bron F-69500, France; Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche en Neurosciences de Lyon, U1028 UMR5292, PSYR2, Bron F-69500, France.
Marine MondinoLe Vinatier, Psychiatrie Universitaire Lyon Métropole, Bron F-69500, France; Université Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche en Neurosciences de Lyon, U1028 UMR5292, PSYR2, Bron F-69500, France.
Simon W DavisDepartment of Psychological and Brain Sciences, Indiana University Bloomington, Bloomington, IN, United States.
Bruce LuberNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.
Sarah H LisanbyNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States; John Shufeldt School of Medicine and Medical Engineering, Arizona State University, Tempe, AZ, United States.
Zhi-De DengNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, United States.

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
Target validation of novel therapeutic agents in mood disordersZIAMH002927 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2010 to 2025
$37.1M
Intramural NIH HHS ZIA MH002927Intramural NIH HHS ZIA MH002955
6 · The paper itself

Abstract

Evidence-based psychotherapies are first-line treatments for psychiatric disorders, yet response rates remain suboptimal. Noninvasive brain stimulation (NIBS) may augment psychotherapy by modulating treatment-engaged circuits. We conducted a systematic review and meta-analysis of randomized controlled trials comparing active NIBS plus evidence-based psychotherapy versus sham NIBS plus psychotherapy. We searched six databases through February 2025, screening 1017 records. Twenty-eight trials (31 treatment arms; 1506 participants) met inclusion criteria. Active NIBS combined with psychotherapy produced significantly greater symptom improvement than sham NIBS with psychotherapy (SMD = -0.38, 95% CI [-0.68, -0.08]), with substantial heterogeneity. Moderator analyses revealed critical implementation parameters: repetitive transcranial magnetic stimulation (rTMS) showed significant benefit while transcranial direct current stimulation did not. Non-concurrent delivery showed significant effects; concurrent delivery did not. Cognitive behavioral therapy (CBT) combined with NIBS showed significant benefit; other psychotherapy modalities did not. Human-delivered psychotherapy significantly enhanced outcomes; computerized formats did not. Significant effects were observed only for anxiety disorders (SMD = -0.70, 95% CI [-1.26, -0.14]). While there was a null finding for depression, it likely reflects insufficient statistical power rather than true ineffectiveness. Secondary analyses found no significant effects on executive functioning or quality of life. Treatment integrity was under-reported: only 39.3% of studies used fully manualized protocols and 10.7% documented therapist adherence. Timing and modality are largely confounded in the current evidence base, and priming versus consolidation effects cannot be distinguished. These findings provide an evidence-based framework for optimizing combined treatment protocols and highlight the need for standardized psychotherapy fidelity monitoring.

Indexed as

Cognitive Behavioral TherapyMental DisordersOutcome Assessment, Health CarePsychotherapyTranscranial Direct Current StimulationTranscranial Magnetic StimulationCombined Modality TherapyHumansMultimodal interventionsNoninvasive brain stimulationPsychopathologyPsychotherapyTranscranial direct current stimulationTranscranial magnetic stimulation

Identifiers

PMID42214517
PMCPMC13551994

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.